| dc.description.abstract | Aim: The purpose of this multicenter descriptive study is to determine the preferences of physiatrists in our country for anti-osteoporotic drugs in patients with primary and secondary osteoporosis. Materials and Methods: This study was carried out in 10 provinces of Turkey. The diagnosis of osteoporosis was based on World Health Organization criteria using dual-energy x-ray absorptiometry. Patients with a spine and/or hip T-score ?-2.5 were considered as osteoporotic. 714 patients over 18 years old with primary or secondary osteoporosis were included in the study. In addition to socio-demographic characteristics and chronic use of medications and/or additional systemic diseases that cause secondary osteoporosis were questioned and antiosteoporotic drugs that are recommended by their physicians were recorded. Results: The physicians' preferred vitamin D and calcium as the prior treatment both in primary and secondary osteoporosis. The most commonly used anti-osteoporotic agent was alendronate from the biphosphonate group. It was followed by ibandronate, risedronate, strontium ranelate, calcitonin, zoledronate, raloxifene, parathyroid hormone (PTH) and hormone replacement therapy (HRT) in the primary osteoporosis and risedronate, ibandronate, calcitonin, strontium ranelate, zoledronate, PTH, HRT and raloxifene in the secondary osteoporosis, respectively. Conclusion: The physician should choose the most suitable treatment for the patient based on fracture risk, medical history, previous treatments for osteoporosis, concomitant diseases, treatment-induced risks and benefits, and the relation between financial cost and potential benefit. | en_US |
| dc.contributor.department | Kutsal, Y.G., Hacettepe Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Ankara, Turkey -- Oz?demir, O., Hacettepe Üniversitesi Kastamonu Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Ankara, Turkey -- Çalişkan, A., Hacettepe Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Ankara, Turkey -- Inanici, F., Hacettepe Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Ankara, Turkey -- Karahan, S., Hacettepe Üniversitesi Tip Fakültesi, Biyoistatistik Anabilim Dali, Ankara, Turkey -- Dog?n, A., Ankara Fizik Tedavi ve Rehabilitasyon E?itim ve Araştirma Hastanesi, 5. Fizik Tedavi ve Rehabilitasyon Klini?i, Ankara, Turkey -- Hizmetli, S., Cumhuriyet Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Sivas, Turkey -- Kamanli, A., Firat Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Elazi?, Turkey -- Kuran, B., Şişli Etfal E?itim ve Araştirma Hastanesi, Fizik Tedavi ve Rehabilitasyon Klini?i, ?stanbul, Turkey -- Öncel, S., Dokuz Eylül Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, ?zmir, Turkey -- Sarikaya, S., Karaelmas Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Zonguldak, Turkey -- Savaş, S., Süleyman Demirel Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Isparta, Turkey -- Şenel, K., Atatürk Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Erzurum, Turkey -- Ugurlu, H., Selcuk Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Konya, Turkey -- Yazgan, P., Harran Üniversitesi Tip Fakültesi, Fiziksel Tip ve Rehabilitasyon Anabilim Dali, Şanliurfa, Turkey | en_US |
